These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32693762)

  • 21. Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape.
    Raikwar S; Jain A; Saraf S; Bidla PD; Panda PK; Tiwari A; Verma A; Jain SK
    Expert Opin Drug Deliv; 2022 Mar; 19(3):247-268. PubMed ID: 35184620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapy.
    Gupta A; Kaur CD; Saraf S; Saraf S
    J Recept Signal Transduct Res; 2017 Jun; 37(3):314-323. PubMed ID: 28095746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy.
    Safdar MH; Hussain Z; Abourehab MAS; Hasan H; Afzal S; Thu HE
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1967-1980. PubMed ID: 29082766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines.
    Geethakumari D; Bhaskaran Sathyabhama A; Raji Sathyan K; Mohandas D; Somasekharan JV; Thavarool Puthiyedathu S
    Int J Biol Macromol; 2022 Feb; 199():150-161. PubMed ID: 34973988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hollow microspheres based on - Folic acid modified - Hydroxypropyl Cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: controlled release of daunorubicin, in vitro and in vivo studies.
    Metaxa AF; Efthimiadou EK; Boukos N; Fragogeorgi EA; Loudos G; Kordas G
    J Colloid Interface Sci; 2014 Dec; 435():171-81. PubMed ID: 25261841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells.
    Kayani Z; Bordbar AK; Firuzi O
    Biomed Pharmacother; 2018 Nov; 107():945-956. PubMed ID: 30257407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
    Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
    Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
    Ezhilarasan D; Lakshmi T; Mallineni SK
    Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin.
    Dramou P; Fizir M; Taleb A; Itatahine A; Dahiru NS; Mehdi YA; Wei L; Zhang J; He H
    Carbohydr Polym; 2018 Oct; 197():117-127. PubMed ID: 30007596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The folate receptor as a rational therapeutic target for personalized cancer treatment.
    Assaraf YG; Leamon CP; Reddy JA
    Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate-mediated delivery of macromolecular anticancer therapeutic agents.
    Lu Y; Low PS
    Adv Drug Deliv Rev; 2002 Sep; 54(5):675-93. PubMed ID: 12204598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate Conjugated Hybrid Nanocarrier for Targeted Letrozole Delivery in Breast Cancer Treatment.
    Hemati Azandaryani A; Kashanian S; Derakhshandeh K
    Pharm Res; 2017 Dec; 34(12):2798-2808. PubMed ID: 29110284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
    Patel NR; Piroyan A; Ganta S; Morse AB; Candiloro KM; Solon AL; Nack AH; Galati CA; Bora C; Maglaty MA; O'Brien SW; Litwin S; Davis B; Connolly DC; Coleman TP
    Cancer Biol Ther; 2018 Jul; 19(7):554-564. PubMed ID: 29737910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate conjugated vs PEGylated phytosomal casein nanocarriers for codelivery of fungal- and herbal-derived anticancer drugs.
    El-Far SW; Helmy MW; Khattab SN; Bekhit AA; Hussein AA; Elzoghby AO
    Nanomedicine (Lond); 2018 Jun; 13(12):1463-1480. PubMed ID: 29957120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer.
    Mukherjee D; Raikwar S
    AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.